S. Jouneau 1, ⁎ , A. Lescoat 2, B. Crestani 3, G. Riemekasten 4, 5, Y. Kondoh 6, V. Smith 7, M.P. Patel 8, J.T. Huggins 9, C. Stock 10, M. Gahlemann 11, M. Alves 12, C.P. Denton 13
1 Service de pneumologie, centre de compétences des maladies respiratoires rares, CHU, université de Rennes, Rennes, France
2 Médecine interne, CHU Hôpital Sud, Rennes, France
3 Hôpital Bichat, pneumologie, Paris, France
4 University Hospital Charité, Rheumatology and Clinical Immunology, Berlin, Allemagne
5 University Hospital Schleswig-Holstein, Rheumatology, Lübeck, Allemagne
6 Department of Respiratory Medicine and Allergy, Tosei General Hospital, Tosei, Japon
7 Department of Rheumatology, Ghent University Hospital, Gand, Belgique
8 Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York Presbyterian Hospital, New York, États-Unis
9 Medical University of South, Charleston, États-Unis
10 Boehringer-Ingelheim Pharma GmbH & Co. KG, Ingelheim, Allemagne
11 Boehringer-Ingelheim (Schweiz) GmbH, Basel, Suisse
12 Boehringer-Ingelheim International GmbH, Ingelheim Am Rhein, Allemagne
13 University College London Division of Medicine, Centre for Rheumatology and Connective Tissue Diseases, Londres, Royaume-Uni